---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-035107"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2023-12-21T23:59:59+00:00"
generated_at: "2026-06-07T09:05:37.618623+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pieris terminates German lease; pays €9.7M to exit ~$22M remaining obligations

## Summary
- Lease termination effective Dec 31, 2023; fee of ~€9.7M paid to landlord.
- Remaining lease payments totaled ~$18.4M, plus ~$3.9M for expansion through 2036.
- Pieris vacates 105,000 sq ft lab/office in Hallbergmoos, retains equipment.
- Limited use of property permitted until June 30, 2024 at no extra cost.
- Part of strategic cost-reduction plan; security deposit to be returned.

## SEC filing metadata
- accession: 0001437749-23-035107
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2023-12-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774923035107/0001437749-23-035107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774923035107/pirs20231107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-035107
- JSON: https://secwatch.observer/filing/0001437749-23-035107.json
- Plain text: https://secwatch.observer/filing/0001437749-23-035107.txt

## Key facts
- Material Agreements
  PALVELLA THERAPEUTICS, INC. terminated Lease Termination Agreement with Hallbergmoos Grundvermögen GmbH valued at termination fee of approximately €9.7 million; remaining lease payments of approximately $18.4 milli (effective 2023-12-15).
  - Action: termination
  - Agreement: lease
  - Counterparty: Hallbergmoos Grundvermögen GmbH
  - Value: termination fee of approximately €9.7 million; remaining lease payments of approximately $18.4 milli
  - Effective: 2023-12-15
  source text: Item 1.02 Termination of a Material Definitive Agreement As previously disclosed, Pieris Pharmaceuticals GmbH ("Pieris GmbH"), a wholly owned subsidiary of Pieris Pharmaceuticals, Inc. (the "Company"), entered into a lease agreement with Hallbergmoos Grundvermögen GmbH ("Lessor") on October 24, 2018, which was subsequently amended on May 21, 2019, February 13, 2020 and May 19, 2020 (collectively, the "Lease Agreement").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583648/000143774923035107/0001437749-23-035107-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.